Cargando…

Author Correction: Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic

Detalles Bibliográficos
Autores principales:	Valero, Sergi, Marquié, Marta, De Rojas, Itziar, Espinosa, Ana, Moreno‑Grau, Sonia, Orellana, Adelina, Montrreal, Laura, Hernández, Isabel, Mauleón, Ana, Rosende‑Roca, Maiteé, Alegret, Montse, Pérez‑Cordón, Alba, Ortega, Gemma, Roberto, Natalia, Sanabria, Angela, Abdelnour, Carla, Gil, Silvia, Tartari, Juan Pablo, Vargas, Liliana, Antonio, Ester Esteban‑De, Benaque, Alba, Tárraga, Lluís, Boada, Mercè, Ruíz, Agustín
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900120/ https://www.ncbi.nlm.nih.gov/pubmed/33619297 http://dx.doi.org/10.1038/s41598-021-84389-1

Ejemplares similares

Interaction of neuropsychiatric symptoms with APOE ε4 and conversion to dementia in MCI patients in a Memory Clinic
por: Sergi, Valero, et al.
Publicado: (2020)

Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis
por: Roberto, Natalia, et al.
Publicado: (2021)

A computerized version of the Short Form of the Face-Name Associative Memory Exam (FACEmemory®) for the early detection of Alzheimer’s disease
por: Alegret, Montserrat, et al.
Publicado: (2020)

Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment
por: Roberto, Natalia, et al.
Publicado: (2021)

Subtle executive deficits are associated with higher brain amyloid burden and lower cortical volume in subjective cognitive decline: the FACEHBI cohort
por: Pérez-Cordón, Alba, et al.
Publicado: (2020)

From Face-to-Face to Home-to-Home: Validity of a Teleneuropsychological Battery
por: Alegret, Montserrat, et al.
Publicado: (2021)

Automatized FACEmemory® scoring is related to Alzheimer’s disease phenotype and biomarkers in early-onset mild cognitive impairment: the BIOFACE cohort
por: Alegret, Montserrat, et al.
Publicado: (2022)

Dementia Care in Times of COVID-19: Experience at Fundació ACE in Barcelona, Spain
por: Benaque, Alba, et al.
Publicado: (2020)

Visual impairment in aging and cognitive decline: experience in a Memory Clinic
por: Marquié, Marta, et al.
Publicado: (2019)

Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative
por: Marquié, Marta, et al.
Publicado: (2020)

The MAPT H1 Haplotype Is a Risk Factor for Alzheimer’s Disease in APOE ε4 Non-carriers
por: Sánchez-Juan, Pascual, et al.
Publicado: (2019)

Evaluation of macular thickness and volume tested by optical coherence tomography as biomarkers for Alzheimer’s disease in a memory clinic
por: Sánchez, Domingo, et al.
Publicado: (2020)

The Spanish version of Face-Name Associative Memory Exam (S-FNAME) performance is related to amyloid burden in Subjective Cognitive Decline
por: Sanabria, Angela, et al.
Publicado: (2018)

Establishing In-House Cutoffs of CSF Alzheimer’s Disease Biomarkers for the AT(N) Stratification of the Alzheimer Center Barcelona Cohort
por: Orellana, Adelina, et al.
Publicado: (2022)

Cut-off Scores of a Brief Neuropsychological Battery (NBACE) for Spanish Individual Adults Older than 44 Years Old
por: Alegret, Montserrat, et al.
Publicado: (2013)

Correction: Cut-off Scores of a Brief Neuropsychological Battery (NBACE) for Spanish Individual Adults Older than 44 Years Old
por: Alegret, Montserrat, et al.
Publicado: (2014)

The Synergic Effect of AT(N) Profiles and Depression on the Risk of Conversion to Dementia in Patients with Mild Cognitive Impairment
por: Marquié, Marta, et al.
Publicado: (2023)

Personality Factors and Subjective Cognitive Decline: The FACEHBI Cohort
por: Muñoz, Nathalia, et al.
Publicado: (2020)

Managing Clinical Trials for Alzheimer’s Disease During the COVID-19 Crisis: Experience at Fundació ACE in Barcelona, Spain
por: Abdelnour, Carla, et al.
Publicado: (2020)

Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer’s disease
por: Sánchez, Domingo, et al.
Publicado: (2018)

Author Correction: Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer’s disease
por: Sánchez, Domingo, et al.
Publicado: (2019)

Differences in macular vessel density in the superficial plexus across cognitive impairment: the NORFACE cohort
por: Marquié, Marta, et al.
Publicado: (2022)

Combination of white matter hyperintensities and Aβ burden is related to cognitive composites domain scores in subjective cognitive decline: the FACEHBI cohort
por: Ortega, G., et al.
Publicado: (2021)

Macular vessel density in the superficial plexus is not associated to cerebrospinal fluid core biomarkers for Alzheimer’s disease in individuals with mild cognitive impairment: The NORFACE cohort
por: Marquié, Marta, et al.
Publicado: (2023)

Social Representation of Dementia: An Analysis of 5,792 Consecutive Cases Evaluated in a Memory Clinic
por: Cañabate, Pilar, et al.
Publicado: (2017)

BIOFACE: A Prospective Study of Risk Factors, Cognition, and Biomarkers in a Cohort of Individuals with Early-Onset Mild Cognitive Impairment. Study Rationale and Research Protocols
por: Esteban de Antonio, Ester, et al.
Publicado: (2021)

Exploring Genetic Associations of Alzheimer’s Disease Loci With Mild Cognitive Impairment Neurocognitive Endophenotypes
por: Espinosa, Ana, et al.
Publicado: (2018)

A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress
por: Morató, Xavier, et al.
Publicado: (2023)

Genome-wide significant risk factors on chromosome 19 and the APOE locus
por: Moreno-Grau, Sonia, et al.
Publicado: (2018)

Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early-onset mild cognitive impairment
por: Cano, Amanda, et al.
Publicado: (2023)

Correlations between the NMR Lipoprotein Profile, APOE Genotype, and Cholesterol Efflux Capacity of Fasting Plasma from Cognitively Healthy Elderly Adults
por: de Rojas, Itziar, et al.
Publicado: (2023)

Harnessing acoustic speech parameters to decipher amyloid status in individuals with mild cognitive impairment
por: García-Gutiérrez, Fernando, et al.
Publicado: (2023)

The role of sex and gender in the selection of Alzheimer patients for clinical trial pre-screening
por: Rosende-Roca, Maitee, et al.
Publicado: (2021)

Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI)
por: de Rojas, Itziar, et al.
Publicado: (2018)

Sex, Neuropsychiatric Profiles, and Caregiver Burden in Alzheimer’s Disease Dementia: A Latent Class Analysis
por: Rosende-Roca, Maitée, et al.
Publicado: (2022)

Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer’s disease in individuals with subjective cognitive decline
por: Pascual-Lucas, María, et al.
Publicado: (2023)

Patient Engagement: The Fundació ACE Framework for Improving Recruitment and Retention in Alzheimer’s Disease Research
por: Boada, Mercè, et al.
Publicado: (2018)

Long runs of homozygosity are associated with Alzheimer’s disease
por: Moreno-Grau, Sonia, et al.
Publicado: (2021)

Blood Amyloid Beta Levels in Healthy, Mild Cognitive Impairment and Alzheimer’s Disease Individuals: Replication of Diastolic Blood Pressure Correlations and Analysis of Critical Covariates
por: Ruiz, Agustín, et al.
Publicado: (2013)

Correction: Blood Amyloid Beta Levels in Healthy, Mild Cognitive Impairment and Alzheimer’s Disease Individuals: Replication of Diastolic Blood Pressure Correlations and Analysis of Critical Covariates
por: Ruiz, Agustín, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7r86fc3p7rbrmea0ou9cltg5o4